1.Pityriasis lichenoides chronica associated with rabies vaccination: A case report
Carmela Franchesca L. Miranda ; Bernadette B. Arcilla ; Lian C. Jamisola ; Camille B. Angeles ; Juanita Carmela Co-Buenviaje
Health Sciences Journal 2024;13(2):111-115
:
Pityriasis lichenoides (PL) is an inflammatory papulosquamous condition that exists in a continuous spectrum that consists mainly of pityriasis lichenoides et varioliformis acuta and pityriasis lichenoides chronica (PLC). The condition has been reported to erupt in response to infections, radiocontrast media, medications and vaccines. Most case reports on vaccine-related eruption involve the acute PL, hence, this report aimed to present a case presenting with lesions of the chronic variant.
:
A 21-year-old female presented with multiple erythematous to hyperpigmented ill defined plaques, some ulceronecrotic, topped with fine scales and excoriations on the upper and lower extremities, periumbilical area and back of 4 months duration, following rabies vaccinations.
:
Histopathologic findings, including interface dermatitis, parakeratosis, spongiosis, and mixed inflammatory infiltrates, confirmed the diagnosis of PLC. The patient responded well to oral corticosteroids and heliotherapy.
PL is rare and requires additional research. The potential role of vaccination as an etiologic agent represented a crucial area of this investigation. Additionally, heliotherapy should be considered as a viable therapeutic alternative when phototherapy is not feasible.. Further research is needed to elucidate the pathogenesis of PL and establish evidence-based treatment protocols.
Pityriasis lichenoides chronica
;
Pityriasis lichenoides
;
heliotherapy
;
vaccine
2.A comparative study of two single-stage oral mucosal substitution urethroplasty (Kulkarni and Asopa) in the surgical treatments of lichen sclerosus urethral strictures.
Xiang WAN ; Hai-Jun YAO ; Min-Kai XIE ; Jian-Shu NI ; Da-Jun GAO ; Zhong WANG ; Bin XU ; Da-Chao ZHENG
Asian Journal of Andrology 2023;25(6):719-724
Long-segment lichen sclerosus (LS) urethral stricture is a challenge for urologists. Limited data are available for surgeons to make a surgical decision between Kulkarni and Asopa urethroplasty. In this retrospective study, we investigated the outcomes of these two procedures in patients with LS urethral stricture. Between January 2015 and December 2020, 77 patients with LS urethral stricture underwent Kulkarni and Asopa procedures for urethroplasty in the Department of Urology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine (Shanghai, China). Of the 77 patients, 42 (54.5%) underwent the Asopa procedure and 35 (45.5%) underwent the Kulkarni procedure. The overall complication rate was 34.2% in the Kulkarni group and 19.0% in the Asopa group, and no difference was observed ( P = 0.105). Among the complications, no statistical difference was observed in the incidence of urethral stricture recurrence ( P = 0.724) or glans dehiscence ( P = 0.246) except for postoperative meatus stenosis ( P = 0.020). However, the recurrence-free survival rate between the two procedures was significantly different ( P = 0.016). Cox survival analysis showed that antiplatelet/anticoagulant therapy use ( P = 0.020), diabetes ( P = 0.003), current/former smoking ( P = 0.019), coronary heart disease ( P < 0.001), and stricture length ( P = 0.028) may lead to a higher hazard ratio of complications. Even so, these two techniques can still provide acceptable results with their own advantages in the surgical treatment of LS urethral strictures. The surgical alternative should be considered comprehensively according to the patient characteristics and surgeon preferences. Moreover, our results showed that antiplatelet/anticoagulant therapy use, diabetes, coronary heart disease, current/former smoking, and stricture length may be contributing factors of complications. Therefore, patients with LS are advised to undergo early interventions for better therapeutic effects.
Male
;
Humans
;
Urethral Stricture/etiology*
;
Retrospective Studies
;
Constriction, Pathologic/surgery*
;
Lichen Sclerosus et Atrophicus/surgery*
;
Treatment Outcome
;
Urologic Surgical Procedures, Male/methods*
;
China
;
Urethra/surgery*
;
Postoperative Complications/etiology*
;
Mouth Mucosa
;
Diabetes Mellitus/etiology*
;
Anticoagulants
;
Coronary Disease
3.Guideline for the diagnosis and treatment of oral lichen planus (revision).
Chinese Journal of Stomatology 2022;57(2):115-121
Oral lichen planus (OLP) is a chronic and inflammatory oral mucosal disease that commonly affects middle-aged females. Most OLP cases might exhibit such symptom as pain, roughness and other discomfort, and more severe forms may show a high risk of developing oral cancer. Active preventive measure, precise diagnosis and standard therapeutic approach play a vital role in the management and prevention of OLP. This guideline is a revision on the base of trial in 2012, which mainly covers the following 8 aspects: etiology and medical records, clinical manifestations, pathological manifestations, diagnosis, differential diagnosis, laboratory examination, disease treatment and prevention, aiming at providing scientific evidence and guidance for the dental clinicians in diagnose and treatment of OLP.
Diagnosis, Differential
;
Female
;
Humans
;
Lichen Planus, Oral/therapy*
;
Middle Aged
;
Mouth Neoplasms
4.Oral lichen sclerosus et atrophicus: a case report.
Wei GUO ; Jiao ZENG ; Jun SHEN
Chinese Journal of Stomatology 2022;57(10):1065-1067
5.Expression and significance of microtubule associated protein 1 light chain 3B, p62 and Beclin1 in lesion tissues of oral lichen planus patients.
Meng Xuan SHEN ; Wen Yun HU ; Yang CAI
Chinese Journal of Stomatology 2022;57(12):1217-1224
Objective: To explore the expression of autophagy related factors microtubule associated protein 1 light chain 3B (LC3B), p62, autophagy key factor Beclin1 in oral lichen planus (OLP) tissues and their relationships with the clinicopathological characteristics of OLP, investigating the function and significance of autophagy in pathogenesis of OLP. Methods: Forty-one lesion tissues (OLP group, twenty-one cases of erosive OLP and twenty cases of non-erosive OLP) were selected from OLP patients visiting the Department of Periodontal and Oral Medicine, School and Hospital of Stomatology, Guizhou Medical University from October 2017 to December 2019. Fifteen cases of normal oral mucosal tissues (control group) were collected from oral and maxillofacial surgery at The Affiliated Stomatology Hospital of Guizhou Medical University during the same period. Protein and mRNA expression levels of LC3B, p62 and Beclin1 were detected by immunohistochemistry (IHC) and real-time quantitative PCR (RT-qPCR) in OLP lesions respectively. The protein expression levels of LC3B, p62, Beclin1 and ratio of LC3B-Ⅱ/LC3B-Ⅰ in sixteen cases (eight cases of erosive OLP and eight cases of non-erosive OLP) from the OLP group were detected by Western blotting (WB). The potential relationship between LC3B, p62, Beclin1, LC3B-Ⅱ/LC3B-Ⅰ ratio and clinical features of OLP were analyzed. Results: IHC results showed that the positive expression rates of LC3B and p62 proteins in OLP lesion tissues [LC3B: 68% (28/41); p62: 59% (24/41)] were higher than those in the control group [LC3B: 5/15; p62: 3/15] (LC3B: χ2=5.55, P=0.019; p62: χ2=5.55, P=0.015). The positive expression rates of LC3B and p62 proteins in the erosive OLP group [LC3B: 86% (18/21); p62: 76% (16/21)] were higher than those in the non-erosive OLP group [LC3B: 50% (10/20); p62: 40% (8/20)] (LC3B: χ2=4.50, P=0.034; p62:χ2=5.53, P=0.019). The positive expression rate of Beclin1 protein in the OLP lesions[20% (8/41)] was lower than that in the control group (7/15) (χ2=4.13, P=0.042), but was not statistically different between the two types of OLP (P>0.05). The RT-qPCR results showed that the mRNA expression levels of LC3B and p62 in OLP lesions [LC3B: 2.78 (1.59, 6.15); p62: 4.30 (2.34, 6.29)] were higher than those in the control group [LC3B: 1.05 (0.88, 1.21); p62: 1.12 (0.89, 1.36)] (LC3B: Z=-4.56, P<0.001; p62: Z=-4.78, P<0.001), and the mRNA expression levels of LC3B and p62 in the erosive OLP group were higher than those in the non-erosive OLP group (LC3B: Z=-2.87, P=0.004; p62: Z=-2.95, P=0.003). The mRNA expression level of Beclin1 in OLP tissues was lower than that in the control group (Z=-2.43, P=0.015), but the difference was not statistically significant between the two types of OLP (P>0.05). WB results showed that the LC3B-Ⅱ/LC3B-Ⅰ ratio was higher in the OLP lesions than that in the control group (t=-2.45, P=0.021), and the LC3B-Ⅱ/LC3B-Ⅰ ratio was higher in the non-erosive OLP group than in the erosive OLP group (t=-2.38, P=0.032). Spearman's correlation analysis showed that the ratio was negatively correlated with the clinical staging and the degree of basal cell liquefaction in OLP (clinical staging: r=-0.57, P=0.021; basal cell liquefaction: r=-0.54, P=0.032), but not with the disease duration and the degree of lymphocytic infiltration (P>0.05). Conclusions: Autophagy related factors LC3B, p62 and Beclin1 may play a role in the formation and progression of OLP lesions. The autophagy level was relatively lack in erosive OLP compared to non-erosive OLP, contributing to the increased local lesion destruction in erosive OLP. Abnormal cellular autophagy may play an important role in the formation of OLP lesions.
Humans
;
Lichen Planus, Oral/metabolism*
;
Beclin-1
;
Microtubule-Associated Proteins/metabolism*
;
Autophagy
;
RNA, Messenger/metabolism*
6.Generalized Purpuric Lichen Nitidus in a 32-year-old Filipino male with Acute Myeloid Leukemia: Case report
Soraya Elisse E. Escandor ; Nicole Marella G. Tan ; Val Constantine S. Cua ; Eileen Leisl A. Cubillan
Acta Medica Philippina 2022;56(13):75-80
A 32-year-old Filipino male managed as a case of acute myeloid leukemia presented with a 6-month history of generalized, red-brown papules. After chemotherapy, the patient was advised 30-minutes daily sun exposure as a form of natural phototherapy. On follow-up, most lesions flattened. This case demonstrates chemotherapy’s potential role in controlling the patient’s inflammatory state and using ultraviolet light therapy in the form of sunlight to manage generalized purpuric lichen nitidus.
Lichen Nitidus
;
Dermoscopy
;
Phototherapy
7.Immune mechanisms involved in the coexistence of oral lichen planus and autoimmune thyroid diseases.
Fan TANG ; Yilong HAO ; Yahui WANG ; Qianming CHEN
Journal of Zhejiang University. Medical sciences 2021;50(2):222-228
Oral lichen planus (OLP) is a chronic inflammatory oral mucosal disease with unclear etiology. Autoimmune thyroid diseases (AITD) is a type of autoimmune disease characterized by increased thyroid-specific antibodies. In recent years, more and more studies have found that the incidence of AITD is increased in OLP patients. The occurrence and development of OLP and AITD may be related to the expression of thyroid autoantigen in oral keratinocytes, the imbalance of thyroid hormone (Th)1/Th2 and Th17/Treg cell subsets, the abnormal quantity and function of follicular helper T cells and chemokines and the specific killing ability of CD8 T cells to target cells. In this article, the possible immune mechanisms involved in the coexistence of OLP and AITD are reviewed to provide insights for the diagnosis, treatment and prevention of these two diseases from the perspective of immunology.
Autoimmune Diseases/complications*
;
Hashimoto Disease
;
Humans
;
Lichen Planus, Oral/complications*
;
Mouth Mucosa
;
Th17 Cells
8.Cross-talk between CXC chemokine ligand 10-CXC chemokine receptor 3 axis and CC chemokine ligand 17-CC chemokine receptor 4 axis in the pathogenesis of oral lichen planus.
Nan TANG ; Yu-Yao ZHANG ; Jue-Hua CHENG ; Zhi-Bai ZHAO ; Yuan FAN
West China Journal of Stomatology 2021;39(4):405-412
OBJECTIVES:
This study aimed to determine whether a correlation existed between CXC chemokine ligand 10 (CXCL10)-CXC chemokine receptor 3 (CXCR3) and CC chemokine ligand 17 (CCL17)-CC chemokine receptor 4 (CCR4) in the pathogenesis of oral lichen planus (OLP).
METHODS:
Peripheral blood of OLP patients (non-erosive and erosive groups) and healthy controls were collected, and T cells were isolated and purified. T cells were co-cultured with three groups: blank, anti-CXCR3, and anti-CCR4. CXCR3 and CCR4 expression were detected by flow cytometry, and CXCL10 and CCL17 were detected by enzyme-linked immunosorbent assay, respectively.
RESULTS:
The purities of T cells were all >95% in the three groups (
CONCLUSIONS
Two axes interact with each other in the pathogenesis of OLP and may play different roles in its occurrence and development.
Chemokine CCL17
;
Chemokine CXCL10
;
Humans
;
Lichen Planus, Oral
;
Ligands
;
Receptors, CCR4
;
Receptors, CXCR3
9.Oral Lichenoid Reactions and Contact Sensitization: A 5-year Review in the Department of Dermatology, Hospital Kuala Lumpur, Malaysia
Sharifah Rosniza Syed Nong Chek ; Min Moon Tang
Malaysian Journal of Dermatology 2021;47(Dec 2021):28-34
Background:
Oral lichen planus is an idiopathic autoimmune inflammatory condition and oral lichenoid reactions
are lesions that resemble oral lichen planus clinically and histopathologically, but develop secondary
to various underlying causes. Oral lichenoid reactions have been reported to be caused by contact
allergy to dental materials. This study aims to describe the characteristics of patients with a clinical
and/or histopathological diagnosis of oral lichen planus who underwent patch testing in Hospital
Kuala Lumpur, Malaysia.
Methods:
This is a 5-year retrospective study of patients who had oral lichen planus and had undergone patch
testing at the Department of Dermatology, Hospital Kuala Lumpur, Malaysia between January 2015
and Cecember 2019. Patch tests were performed with European Baseline Series and relevant extended
series, which include dental and metal series as well as patients’ own products. Patch test results were
recorded according to the International Contact Dermatitis Research Group recommendation.
Results:
There were 41 patients with oral lichen planus who underwent patch test. The median age was 56
(range 21 to 73) with 70.7% of patients being female. There were 29 (70.7%) patients who developed
at least one positive reaction. The most frequent sensitizing allergens were nickel sulfate (34.1%),
gold(I)sodium thiosulphate dihydrate (22.0%), fragrance mix I (19.5%), cobalt chloride (14.6%),
Peru balsam (12.2%) and sodium tetrachloropalladate (II) hydrate (12.2%). Current relevance was
recorded in 16 patients (39.0%) and of these patients, 12 of them had positive patch test reactions
to allergens found in dental materials such as dental fillings, dental implants, orthodontic braces,
dentures and dental crowns.
Conclusion
Contact sensitization was detected in about 70% of our patients with oral lichen planus. The most
common sensitizing allergen was nickel sulfate. Current relevance was found mainly towards dental
materials.
Lichen Planus, Oral--diagnosis
;
Dermatitis, Allergic Contact
;
Department of Dermatology, Hospital Kuala Lumpur (Malaysia)
10.Efficacy and safety of Nocardia rubra cell wall skeleton for the treatment of erosive oral lichen planus.
Zheng Da ZHU ; Yan GAO ; Wen Xiu HE ; Xin FANG ; Yang LIU ; Pan WEI ; Zhi Min YAN ; Hong HUA
Journal of Peking University(Health Sciences) 2021;53(5):964-969
OBJECTIVE:
To observe the efficacy and safety of Nocardia rubra cell wall skeleton (Nr-CWS) for the treatment of erosive oral lichen planus (EOLP).
METHODS:
Sixty patients with clinically and pathologically diagnosed EOLP were randomly divided into the experimental group and control group according to the random number. Patients in the experimental group were treated with lyophilized powder containing Nr-CWS combined with normal saline. Patients in the control group received topical placebo without Nr-CWS combined with normal saline. Changes in the EOLP lesion area and the patient's pain level were recorded at the timepoints of weeks 1, 2, and 4 after the two different treatments, respectively. The changes of the patient's REU scoring system (reticulation, erythema, ulceration), the visual analogue scale and the oral health impact score (OHIP-14) were compared between the experimental group and control group after treatment, and the safety indicators of the two groups at the initial diagnosis and after 4 weeks' treatment were also observed, respectively.
RESULTS:
Totally, 62 patients with clinically and pathologically diagnosed EOLP were enrolled, 2 of whom were lost to the follow-up, with 31 in the experimental group, and 29 in the control group. The mean age of the experimental group and control group were (52.9±12.4) years and (54.07±12.40) years, respectively. There was no significant difference in the oral periodontal index between the experimental group and control group. In the experimental group, the erosive area of oral lichen planus was significantly reduced 1, 2, and 4 weeks after the Nr-CWS's treatment (P < 0.05), the reduction rate was 81.75%, the patient's pain index was also decreased (P < 0.05), and in addition, the OHIP-14 was reduced (P < 0.05). The changes of the REU scoring system, the visual analogue scale and the OHIP-14 were significantly different between the experimental group and control group after treatment. There was no significant difference in the safety index between the two groups.
CONCLUSION
The priliminary data show that the Nr-CWS is effective and safe to treat EOLP.
Adult
;
Aged
;
Cell Wall Skeleton
;
Humans
;
Lichen Planus, Oral/drug therapy*
;
Middle Aged
;
Pain Measurement
;
Rhodococcus


Result Analysis
Print
Save
E-mail